Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2)

J Med Chem. 2007 Apr 5;50(7):1693-7. doi: 10.1021/jm061160+. Epub 2007 Mar 13.

Abstract

Synthesis and biological activity of a novel class of quaternary ammonium salt muscarinic M3 receptor antagonists, showing high selectivity versus the M2 receptor, are described. Selected compounds exhibited potent anticholinergic properties, in isolated guinea-pig trachea, and good functional selectivity for trachea over atria. In vivo, the same compounds potently inhibited acetylcholine-induced bronchoconstriction after intratracheal administration in the guinea pig.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bronchoconstriction / drug effects
  • Bronchodilator Agents / chemical synthesis
  • Bronchodilator Agents / chemistry*
  • Bronchodilator Agents / pharmacology
  • CHO Cells
  • Cricetinae
  • Cricetulus
  • Guinea Pigs
  • Humans
  • Imidazolidines / chemical synthesis*
  • Imidazolidines / chemistry
  • Imidazolidines / pharmacology
  • In Vitro Techniques
  • Male
  • Muscle Contraction / drug effects
  • Muscle, Smooth / drug effects
  • Muscle, Smooth / physiology
  • Myocardial Contraction / drug effects
  • Quaternary Ammonium Compounds / chemical synthesis*
  • Quaternary Ammonium Compounds / chemistry
  • Quaternary Ammonium Compounds / pharmacology
  • Radioligand Assay
  • Receptor, Muscarinic M3 / antagonists & inhibitors*
  • Structure-Activity Relationship
  • Trachea / drug effects
  • Trachea / physiology

Substances

  • Bronchodilator Agents
  • Imidazolidines
  • Quaternary Ammonium Compounds
  • Receptor, Muscarinic M3